Molly Burich, MS, is the Senior Director of Reimbursement and Policy at Otsuka Pharmaceuticals Inc. where she leads the policy and reimbursement team at Otsuka. Ms. Burich develops Otsuka’s strategic policy platform to support Otsuka’s products. Ms. Burich was formerly the Head of Public Policy at Boehringer Ingelheim, Inc. In her role she led the public policy  team at Boehringer with specific focus on biosimilars and oncology as well as reimbursement across the existing and pipeline portfolio for Boehringer Ingelheim.  Ms. Burich has held previous positions in federal and state government affairs, public policy and reimbursement across other organizations including Xcenda, an Amerisource Bergen company and Avalere Health. Ms. Burich holds a master of science in public service management with an emphasis in public policy from DePaul University and a bachelor of arts in political science from the University of Northern Colorado.